Lexpos News

/Lexpos News

PQS: 31st March deadline approaches

Pharmacy owners have until the end of Tuesday 31st March 2026 to have their evidence to demonstrate meeting the 2025/26 Pharmacy Quality Scheme (PQS) domains that they have claimed for. Pharmacy owners were required to complete a PQS declaration between 9am on 2nd February 2026 and 11.59pm on 27th February 2026. However, pharmacy owners have [...]

The post PQS: 31st March deadline approaches appeared first on Community Pharmacy England.

By |March 24th, 2026|Lexpos News|Comments Off on PQS: 31st March deadline approaches

March 2026 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (24/03/2026) confirmed the following list of price concessions for March 2026: Drug Pack size Price concession Adapalene 0.1% cream 45 £18.26 Adapalene 0.1% gel 45 £18.26 Alfuzosin 2.5mg tablets 60 £6.67 Amlodipine 2.5mg tablets 28 £3.88 Aripiprazole 15mg tablets 28 £1.02 Aspirin 75mg dispersible tablets 28 [...]

The post March 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

By |March 24th, 2026|Lexpos News|Comments Off on March 2026 Price Concessions 2nd Update

Call for swift movement on flexibilities and reimbursement changes to tackle supply issues

The Royal Pharmaceutical Society (RPS) – supported by Community Pharmacy England, charities and patient groups – is calling on the Government to make headway in introducing community pharmacist flexibilities and addressing reimbursement issues that can delay access to medicines. Medicines Shortages: One Year On assesses progress on supply issues since the launch of the RPS’s [...]

The post Call for swift movement on flexibilities and reimbursement changes to tackle supply issues appeared first on Community Pharmacy England.

By |March 24th, 2026|Lexpos News|Comments Off on Call for swift movement on flexibilities and reimbursement changes to tackle supply issues

MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care)

MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) Drug alert number: EL(26)A/15 Date issued: 23 March 2026 Mölnlycke Health Care are recalling specific batches of Hibiwash® due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. DMRC reference number: DMRC-38814497 Company name:Regent Medical Limited / Mölnlycke Health [...]

The post MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) appeared first on Community Pharmacy England.

By |March 23rd, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care)

CPE Comms: Are you getting what you need from us?

A short survey has opened to hear what pharmacy owners think of Community Pharmacy England’s communications and how they could be improved. As we approach three years on from our rebrand to Community Pharmacy England, we’re taking a fresh look at how we communicate and engage with you. Your insight is vital to helping us [...]

The post CPE Comms: Are you getting what you need from us? appeared first on Community Pharmacy England.

By |March 23rd, 2026|Lexpos News|Comments Off on CPE Comms: Are you getting what you need from us?